Labour-efficient approach to IBR control
The current estimate is that between 70-80% of beef and dairy herds in Ireland are endemically infected¹, with adult cows being latent carriers of infection.
IBR is not commonly seen in young calves below three months-of-age. In most dairy herds, calves are removed from dairy cows very shortly after birth and reared separately. Therefore, they may remain “clean” or “naïve” throughout the rearing and first breeding season until they mix with the adult herd.
This is a very stressful time for dairy heifers, which makes them more susceptible to disease if the virus is endemic in the herd. In many dairy herds the common disease pattern is that heifers become infected when they mix with older animals (e.g. during their first winter).
What causes IBR?
‘IBR’ stands for ‘infectious bovine rhinotracheitis’ and is caused by bovine herpes virus 1 (BoHV1).
Primary infection occurs when a naïve animal is exposed to the IBR virus through the nose or mouth following direct contact with an animal shedding the virus2, or indirectly via fomites or airborne transmission and is commonly associated with clinical signs of acute IBR disease which range from mild to severe.
As IBR is caused by a herpes virus, not dissimilar to the human cold sore virus, it means that once an animal has been infected, it will become a latent carrier for life. Latent carriers are a potential source of infection and can shed virus at times of stress (e.g. transport, calving, nutritional stress) resulting in disease in the in-contact (naïve) animals².
In adult dairy cows, sudden reduced milk production can be a feature of the disease.
How can you protect the herd from IBR?
Vaccination increases the overall immunity of the herd, and reduces shedding of the virus from carrier animals, protecting the herd from a potential disease breakdown.
Live IBR vaccines are best used in naïve animals (e.g. calves and weanlings) to protect them from clinical disease. Live vaccines work rapidly and stimulate immunity most similarly to natural infection.
This is because the virus is live (but altered to make it safe) so it can replicate in the body, and therefore the body responds to it in a similar manner to the way it would to a natural infection. Studies have found that live vaccines are better at protecting naïve animals from clinical disease compared to inactivated ones4.
Inactivated IBR vaccines are best used in latently infected animals (e.g. adult dairy cows) to stop or reduce viral shedding.
Inactivated vaccines stimulate immunity in a slightly different way to the live vaccines and have been found to be better at reducing viral shedding in animals which have previously been infected and are carrying the virus (latently infected carrier animals)5.
In a dairy herd with a high bulk milk antibody level, which suggests that a high proportion of the milking cows are already infected, use of an inactivated vaccine can better help to reduce the amount of the virus these cows shed when under stress. This reduces the risk to any uninfected animals, or heifers entering the herd.
Tried and trusted programme
The Rispoval Yearly IBR Programme has been tried and tested in Ireland since 2012, with both vets and farmers nationwide confident that they can rely on Rispoval for IBR protection.
An ongoing study6 in a closed 230-cow dairy herd in Scotland using Live IBR Marker vaccine in heifer weanlings and Inactivated IBR Marker vaccine in cows has generated some interesting field data.
In this farm within seven years of re‐starting a vaccination programme, the adult cow herd seroprevalence has fallen from 99% to 8%, meaning this dairy farm is now close to achieving IBR eradication (Fig. 1).
The remaining 8% seropositive cows were first lactation cows or pregnant heifers during the outbreak in 2012 and had therefore become latent carriers at that time.
A single dose of Rispoval IBR Marker Live in June/July will set up weanling heifers to join the Rispoval Yearly IBR programme this coming winter, when dairy farmers have more time to vaccinate the whole herd.
With the Rispoval Yearly IBR programme, animals over three months-of-age receive a single dose of Rispoval IBR Live (intramuscularly) followed by a single dose of Rispoval IBR Inactivated (under the skin) within six months. A yearly booster of Rispoval IBR Inactivated is then required.
Rispoval Yearly IBR vaccination
Year 1: Cattle over three months-of-age receive one dose of Rispoval IBR-Marker Live (intramuscularly) followed by one dose of Rispoval IBR-Marker Inactivated within six months. This dose of Rispoval IBR-Marker Inactivated provides one year of IBR protection.
Year 2: A single yearly booster of Rispoval IBR Marker Inactivated should be given.
Advantages of the Rispoval Yearly IBR programme:
- Lifetime herd approach;
- IBR protection for all animals from a young age;
- Clear, simple message for farmers;
- Reduction of virus shedding from existing latent carriers;
- Prevention of IBR abortion**;
- Labour saving as fewer vaccines required;
- Vaccination of the entire herd in December is both convenient and effective;
- Combining a live and an inactivated vaccine stimulates the immune response in different ways, resulting in a more complete immunity;
- No need to assess herd seroprevalence. It simply suits all herds.
**In order to prevent abortion in female cattle that have only received their first single dose of Rispoval IBR-Marker live, the booster with Rispoval IBR-Marker Inactivated should be given no later than by the start of the second trimester of pregnancy.
- DJ Bosco Cowley, Tracy A Clegg, Michael L Doherty, Simon J More (2011) Aspects of bovine herpesvirus‐1 infection in dairy and beef herds in the Republic of Ireland, Acta Veterinaria Scandinavica 53:40;
- Graham (2013) Bovine herpes virus‐1 (BoHV‐1) in cattle‐a review with emphasis on reproductive impacts and the emergence of infection in Ireland and the United Kingdom, Irish veterinary Journal, 66:15;
- Muylkens, B., Thiry, J., Kirten, P., Schynts, F., Thiry, E., 2007, Bovine herpesvirus 1 infection and infectious bovine rhinotracheitis. Veterinary Research 38, 181‐209;
- Bosch, J.C., M.J. Kaashoek, A.H. Kroese, J.T. van Oirschot (1996). An attenuated bovine herpes virus 1 marker vaccine induces better than two inactivated marker vaccines. Vet. Microbiol., 52: 223-234;
- Bosch J.C., Kaashoek M.J., van Oirschot J.T. (1997). Inactivated bovine herpesvirus 1 marker vaccines are more efficacious in reducing virus excretion after reactivation than a live marker vaccine. Vaccine 15:1512-1517;
- The University of Edinburgh- Dairy Herd Health and Productivity Centre- Aug 2019- Newsletter.
Rispoval® IBR Marker Live contains Bovine Herpes Virus type 1 (BHV-1), strain Difivac (gEnegative), modified live (attenuated) virus. Legal Status: POM(E).
Rispoval® IBR Marker Inactivated contains Bovine Herpes Virus type 1 (BoHV-1), strain Difivac (gE-negative) Legal Status: POM(E).
For further information, please contact Zoetis, 2nd Floor, Building 10, Cherrywood Business Park, Loughlinstown, Co. Dublin on: 01-2569800; or: www.zoetis.ie. Use medicines responsibly; see: www.apha.ie.